Monitoring Myeloma: How Blood, Urine, and Imaging Tests Impact Treatment Decisions
Join us on Tuesday, August 5, 2025 at 3pm PDT | 6pm EDT (U.S.)
Lab tests play a central role in diagnosing and managing multiple myeloma, yet they can feel confusing and overwhelming.
In this expert conversation, Dr. Brandon Blue of Moffitt Cancer Center sits down with Bryon Daily, a multiple myeloma patient and community leader from The Leukemia & Lymphoma Society, to break it all down in real terms.
They share honest insights on:
- Imaging tests explained: X-ray, MRI, PET
- Find out how lab work helps guide treatment decisions
- What labs indicate a relapse or treatment change
- Using biomarkers in clinical trials
Thank you to The Leukemia & Lymphoma Society for their partnership. The Leukemia & Lymphoma Society is here for you with information about clinical trials, resources, and dedicated support through their Information Specialists.
From groundbreaking studies to insightful patient stories, MPN Research Foundation is at the forefront of making real change for those directly affected by essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).
Register for this informative program then invite a Friend or Care Partner.
Whether you’re newly diagnosed or have been living with multiple myeloma for years, this conversation is for you.
